Wed Jan 30, 2013 10:46 AM CST

(Dow Jones) -- Monsanto Co. has bought assets from a California-based company that uses microbes to improve crop production.

Monsanto also said that it made an equity investment in Synthetic Genomics Inc. and that the two companies reached a multiyear agricultural research agreement

The purchase of assets from Agradis, which Synthetic Genomics co-founded in 2011, includes the collection of microbes as well as the company's name. Terms of the deal weren't disclosed.

The assets build upon Monsanto's agricultural biological platform, called BioDirect, launched last year. Agricultural biologicals generally refer to seed or crop treatments derived from natural materials.

Agradis has ...

Quick View
Related News Stories
Senators Elevate Biotech Talk
Dr. Dan Talks Agronomy
Attorneys Dive Into Corn Case
Rootworm Shows Up Late Season
Syngenta Attorney Details Case
Pre-Order Opportunities
MIR 162 Litigation Update
Crop Tech Corner
Silent Biotech Dialogue
Dr. Dan Talks Agronomy